Welcome to our dedicated page for Hydromer news (Ticker: HYDI), a resource for investors and traders seeking the latest updates and insights on Hydromer stock.
Hydromer, Inc. (HYDI) specializes in advanced bio-polymer coating technologies for medical, industrial, and consumer applications. This page serves as the definitive source for investors and industry professionals tracking the company’s financial developments, product innovations, and strategic partnerships.
Access real-time updates on earnings reports, regulatory filings, and technology advancements directly from Hydromer’s leadership team. Our curated collection includes press releases covering new patent approvals, manufacturing expansions, and collaborations with global healthcare and industrial partners.
Key content categories include quarterly financial results, R&D milestones for hydrophilic/antimicrobial coatings, FDA clearance announcements, and executive leadership updates. All materials are sourced from official company communications to ensure accuracy and compliance with financial disclosure standards.
Bookmark this page for streamlined access to Hydromer’s evolving business narrative, supported by four decades of polymer science expertise and ISO-certified quality systems. Check back regularly for authoritative updates on this innovative materials technology leader.
Hydromer (OTC: HYDI) reported preliminary unaudited Q3 2024 financial results. Revenue decreased 21% to $788,000 compared to $993,000 in Q3 2023. Cost of goods sold decreased 28% to $134,000, while gross profit declined 19% to $654,000. Operating expenses reduced by 24% to $583,000. Despite revenue challenges due to raw material management issues and reduced legacy program orders, net income increased 67% to $72,000 from $43,000 in the same period last year.
Hydromer, Inc. (OTC: HYDI), a leader in hydrophilic coating technologies, has announced the formation of a new Research and Development (R&D) division. This restructuring introduces a world-class science team focused on innovation and performance, adding two Ph.D. chemists and one M.S. chemist. Dr. Yonghua Zhou, Ph.D. in Polymer Science, will lead the team, bringing extensive experience in polymer science and new product development.
The company aims to enhance product offerings, improve operational efficiency, and drive future growth. Under new executive leadership, Hydromer has refocused on improving financial reporting, enhancing operational efficiencies, and advancing coating technologies. The R&D team will work on developing advanced coatings that are more durable and environmentally friendly, addressing growing regulatory restrictions on harmful solvents.
CEO Mike Torti stated that this strategic move is expected to reposition Hydromer as a leader in product development and innovation, opening new doors and markets for the company's growth.
Hydromer, Inc. (OTC: HYDI) announced preliminary unaudited Q2 2024 financial results and provided a business update. Key highlights include:
1. Revenue decreased 32% to $836,000 compared to Q2 2023.
2. Cost of Goods Sold reduced by 23% to $129,000.
3. Operating Expenses decreased by 8% to $713,000.
4. Net Ordinary Income declined 102% to a loss of $6,700.
5. Net Income decreased 97% to $30,000.
The company attributed the sales decline to customer attrition and insufficient sales efforts. However, Hydromer secured 12 new R&D projects and signed contracts with 6 new customers for coating services. The company remains committed to strengthening operations and sales strategies.
Hydromer, Inc. reported positive financial results for the first quarter of 2024, with revenue increasing to $1,093,000, a growth of 8% compared to the same period in 2023. Operating expenses decreased by 25% to $622,000, and net income surged by 754% to $333,000. The company emphasized strategic growth initiatives and profitability, aiming to enhance shareholder value through new product development and targeted sales campaigns.
